Christian Parul, Shrestha Jaibar, LeClerq Steven C, Khatry Subarna K, Jiang Tianan, Wagner Tracey, Katz Joanne, West Keith P
Center for Human Nutrition, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
J Nutr. 2003 Nov;133(11):3492-8. doi: 10.1093/jn/133.11.3492.
Iron deficiency is one of the main causes of anemia during pregnancy, although other micronutrient deficiencies may play a role. We examined the effects of daily antenatal and postnatal supplementation with four combinations of micronutrients on maternal hematologic indicators in a double-masked randomized controlled community trial. Communities, called sectors, were randomly assigned to supplementation with folic acid (400 microg), folic acid plus iron (60 mg), folic acid plus iron and zinc (30 mg) and folic acid plus iron, zinc and 11 other micronutrients, each at the approximate recommended daily allowance for pregnancy all given with vitamin A as retinol acetate (1000 microg retinol equivalent), or vitamin A alone as the control group. Hemoglobin (Hb) and indicators of iron status were assessed at baseline and at 32 wk of gestation. At 6-wk postpartum, Hb assessment was repeated using a finger stick. Severely anemic women (Hb < 70 g/L) were treated according to WHO recommendations. Folic acid alone had no effect on maternal anemia or iron status. Hb concentrations were 14 g/L, [95% confidence limits (CL), 8.3-19.2], 10.0 g/L (CL, 5.2-14.8) and 9.4 g/L (CL, 4.7-14.1) higher in the groups receiving folic acid plus iron, folic acid plus iron and zinc and folic acid plus iron, zinc and multiple micronutrients, respectively, relative to the control. Anemia in the third trimester was reduced by 54% with folic acid plus iron, by 48% with folic acid plus iron and zinc and by 36% with folic acid plus iron, zinc and multiple micronutrients supplementation, relative to the control (P < 0.05). Thus, the combinations of folic acid plus iron and zinc and folic acid plus iron, zinc and multiple micronutrients provided no additional benefit in improving maternal hematologic status during pregnancy compared with folic acid plus iron. The level of compliance and baseline Hb concentrations modified the effect of iron.
缺铁是孕期贫血的主要原因之一,不过其他微量营养素缺乏可能也起一定作用。在一项双盲随机对照社区试验中,我们研究了每日产前和产后补充四种微量营养素组合对孕产妇血液学指标的影响。社区(称为分区)被随机分配接受叶酸(400微克)、叶酸加铁(60毫克)、叶酸加铁和锌(30毫克)以及叶酸加铁、锌和其他11种微量营养素补充,每种补充剂的剂量均为孕期大致推荐日摄入量,所有补充剂均与视黄醇醋酸酯形式的维生素A(1000微克视黄醇当量)一起服用,或单独补充维生素A作为对照组。在基线期和妊娠32周时评估血红蛋白(Hb)和铁状态指标。产后6周时,采用手指采血法重复进行Hb评估。严重贫血妇女(Hb < 70克/升)根据世界卫生组织的建议进行治疗。单独补充叶酸对孕产妇贫血或铁状态没有影响。与对照组相比,接受叶酸加铁、叶酸加铁和锌以及叶酸加铁、锌和多种微量营养素补充的组中,Hb浓度分别高出14克/升[95%置信区间(CL),8.3 - 19.2]、10.0克/升(CL,5.2 - 14.8)和9.4克/升(CL,4.7 - 14.1)。与对照组相比,在孕晚期,补充叶酸加铁使贫血减少了54%,补充叶酸加铁和锌使贫血减少了48%,补充叶酸加铁、锌和多种微量营养素使贫血减少了36%(P < 0.05)。因此,与叶酸加铁相比,叶酸加铁和锌以及叶酸加铁、锌和多种微量营养素组合在改善孕期孕产妇血液学状况方面没有额外益处。依从性水平和基线Hb浓度改变了铁的作用效果。